Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-005525
Filing Date
2024-02-08
Accepted
2024-02-08 21:27:43
Documents
3
Period of Report
2024-01-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2213
2 ex24.htm EX-24 1098
3 ex24_001.jpg GRAPHIC 325828
  Complete submission text file 0001493152-24-005525.txt   453733
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5152
FibroBiologics, Inc. (Issuer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11 ARBOR WALK LANE RANCHO SANTA MARGARITA CA 92688
Business Address
Khoja Hamid (Reporting) CIK: 0002010662 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41934 | Film No.: 24610924